Updates in Advanced Renal Cell Carcinoma from The 2022 International Kidney Cancer Symposium - Episode 3
Drs Hans Hammers reviews updated efficacy data on the use of lenvatinib plus pembrolizumab for frontline advanced renal cell carcinoma treatment.